Financials
- Market Capitalization 9.63 B
- Employee 11 K
- Founded 2015
- CEO N/A
- Website www.praxismedicines.com
- Headquarter Delaware, United States
- FIGI BBG00W9LF2G5
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-25.85
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 923 | KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.08 USD | -2.16% | -1.54% | +0.54% | +96.95% | 9.93 B USD | ||
| 931 | KYMR Kymera Therapeutics, Inc. - Common Stock | 118.15 USD | -1.73% | -0.39% | +11.20% | +99.92% | 9.82 B USD | ||
| 961 | PTGX Protagonist Therapeutics, Inc. - Common Stock | 144.33 USD | -3.46% | -6.47% | +4.31% | +92.11% | 9.34 B USD | ||
| 982 | CRNX Crinetics Pharmaceuticals, Inc. - Common Stock | 84.84 USD | -0.01% | +0.15% | +1.33% | +106.42% | 9.00 B USD |